Search Within

Richard Jirui Lin

  1. "Biostatistics Service"
Formats
  1. Meeting Abstract (41)
  2. Journal Article (28)
  3. Research Letter (6)
Groups
  1. Biostatistics Service (75)
  2. Bone Marrow Transplant (75)
  3. Center for Hematologic Malignancies (75)
  4. Department of Medicine (75)
  5. Epidemiology and Biostatistics (75)
  6. Hematologic Malignancies, Division of (75)

More Groups

People
  1. Miguel-Angel Perales (71)
  2. Sean Devlin (69)
  3. Parastoo Dahi (64)
  4. Gunjan Shah (60)
  5. Michael Scordo (57)
  6. Sergio Giralt (56)

More People

Years
  1. 2025 (5)
  2. 2024 (11)
  3. 2023 (25)
  4. 2022 (8)
  5. 2021 (2)
  6. 2020 (13)

More Years

Publications
  1. Blood (23)
  2. Bone Marrow Transplantation (12)
  3. Biology of Blood and Marrow Transplantation (6)
  4. Transplantation and Cellular Therapy (6)
  5. Blood Advances (5)
  6. American Journal of Hematology (2)

More Publications

Publishers
  1. American Society of Hematology (28)
  2. Nature Publishing Group (16)
  3. Elsevier Inc. (13)
  4. American Society of Clinical Oncology (2)
  5. Ferrata Storti Foundation (2)
  6. John Wiley & Sons (2)

More Publishers

Results (75)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact and safety of chimeric antigen receptor T-cell therapy in older, vulnerable patients with relapsed/refractory large B-cell lymphoma
    Research Letter

    Lin, R. J.; Lobaugh, S. M.; Pennisi, M.; Chan, H. T.; Batlevi, Y.; Ruiz, J. D.; Elko, T. A.; Maloy, M. A.; Batlevi, C. L.; Dahi, P. B.; more...
    Haematologica (2021)

    Fulltext@MSK | Save
  • A pilot study evaluating lenalidomide and CC-486 in combination with radiotherapy for patients with plasmacytoma (LENAZART study)
    Meeting Abstract

    Shah, U. A.; Werner, K.; Tavitian, E.; Devlin, S.; Mailankody, S.; Korde, N.; Hultcrantz, M.; Tan, C.; Lu, S. X.; Smith, E. L.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Clinical impact of bridging therapy prior to commercial chimeric antigen receptor (CAR) T-cell therapies for relapsed/refractory lymphomas
    Meeting Abstract

    Imber, B. S.; Perales, M. A.; Flynn, J.; Ruiz, J. D.; Devlin, S.; Alarcon Tomas, A.; Hajj, C.; Batlevi, C. L.; Dahi, P. B.; Lin, R. J.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Implications of novel risks scores (AML-DRG and AML-HCT-CR) in allogeneic CD34+ selected graft transplant outcomes
    Meeting Abstract

    Trillo, R. A.; Recio, M. G.; Pennisi, M.; Cho, C.; Devlin, S. M.; Ruiz, J. D.; Maloy, M. A.; Tomas, A. A.; Castillo, N.; Lin, R. J.; more...
    Bone Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Impact of allogeneic hematopoietic cell transplantation on immune evasive mechanisms in relapsed refractory large B-cell lymphoma
    Research Letter

    Lin, R. J.; Ho, C.; Devlin, S. M.; Ruiz, J. D.; Maloy, M. A.; Shah, G. L.; Perales, M. A.; Dahi, P. B.; Giralt, S. A.; Scordo, M.; more...
    Bone Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Characteristics and impact of post-transplant interdisciplinary palliative care consultation in older allogeneic hematopoietic cell transplant recipients
    Journal Article

    Lin, R. J.; Cohen, A. G.; Stabler, S. M.; Devlin, S. M.; Elko, T. A.; Maloy, M. A.; Korc-Grodzicki, B.; Alexander, K.; Kramer, D.; Sanchez-Escamilla, M.; more...
    Journal of Palliative Medicine (2020)

    Fulltext@MSK | Save
  • Outcomes in patients with DLBCL treated with commercial CAR T cells compared with alternate therapies
    Journal Article

    Sermer, D.; Batlevi, C.; Lia Palomba, M.; Shah, G.; Lin, R. J.; Perales, M. A.; Scordo, M.; Dahi, P.; Pennisi, M.; Afuye, A.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • The geriatric syndrome of sarcopenia impacts allogeneic hematopoietic cell transplantation outcomes in older lymphoma patients
    Journal Article

    Lin, R. J.; Michaud, L.; Lobaugh, S. M.; Nakajima, R.; Mauguen, A.; Elko, T. A.; Ruiz, J. D.; Maloy, M. A.; Sauter, C. S.; Dahi, P. B.; more...
    Leukemia and Lymphoma (2020)

    Fulltext@MSK | Save
  • Favorable long-term outcomes of hematopoietic stem cell transplantation for CMML with myeloablative conditioning, anti-thymocyte globulin, and CD34(+) selected graft
    Research Letter

    Lin, R. J.; Sanchez, M.; Abbi, K.; Devlin, S. M.; Jakubowski, A. A.; Papadopoulos, E. B.; Barker, J. N.; Tamari, R.; Young, J. W.; Gyurkocza, B.; more...
    Bone Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • The impact of individual co-morbidities in myeloablative ex vivo CD34+ selected allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Shouval, R.; Fein, J. A.; Devlin, S. M.; Maloy, M. A.; Castillo Flores, N.; Lin, R. J.; Politikos, I.; Sanchez, M.; Scordo, M.; Shah, G. L.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save